Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,4.082130511346204e-62,195.01436781609195,27565.994005567445,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",9.797113227230888e-60,0,0,70
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,3.200316571960203e-29,26.057339808867304,1709.6668304100713,"['COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UCP3', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'SLC25A5']",3.8403798863522436e-27,0,0,43
3,Nonalcoholic fatty liver disease WP4396,1.6890471857023385e-21,15.132267287938156,723.7781962443596,"['NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",1.3512377485618708e-19,0,0,37
4,Oxidative phosphorylation WP623,3.105190960769527e-14,18.48611111111111,574.9756598928967,"['ATP5PF', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'NDUFA11', 'NDUFB10', 'NDUFA5', 'NDUFB5', 'NDUFA4', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'ATP5MF', 'ATP5ME']",1.863114576461716e-12,0,0,22
5,Mitochondrial CIV Assembly WP4922,1.170023908423797e-12,39.927927927927925,1096.9797694240492,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",5.616114760434226e-11,0,0,16
6,Mitochondrial complex I assembly model OXPHOS system WP4324,2.957528386386397e-12,25.490135396518376,676.6781412798621,"['NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'TMEM186', 'NDUFS6', 'NDUFS5']",1.1830113545545587e-10,0,0,17
7,Mitochondrial complex III assembly WP4921,4.372214242583031e-08,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",1.4990448831713247e-06,0,0,8
8,Pyrimidine metabolism WP4022,5.939145163241086e-06,7.411877394636015,89.19412748466435,"['NT5C', 'POLE4', 'POLD4', 'ZNRD1', 'POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR2K', 'NME1', 'POLR2L']",0.00017817435489723258,0,0,12
9,Cellular Proteostasis WP4918,0.0009576590170123114,29.28301886792453,203.54681395396412,"['VBP1', 'PFDN4', 'PFDN5', 'PFDN6']",0.02553757378699497,0,0,4
10,DNA Repair Pathways Full Network WP4946,0.005822339565171062,4.888888888888889,25.158481875370224,"['POLE4', 'POLD4', 'DCLRE1C', 'CENPX', 'APEX1', 'POLE3']",0.125700772811783,0,0,6
11,mRNA Processing WP411,0.00628503864058915,6.104284814114682,30.94618028428354,"['LSM7', 'SNRPD1', 'SNRPE', 'SRSF9', 'LSM2']",0.125700772811783,0,0,5
12,Proteasome Degradation WP183,0.00628503864058915,6.104284814114682,30.94618028428354,"['PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMB10']",0.125700772811783,0,0,5
13,Base Excision Repair WP4752,0.009928112673087812,7.315094339622641,33.74003054337529,"['POLE4', 'POLD4', 'APEX1', 'POLE3']",0.18328823396469807,0,0,4
14,DNA Mismatch Repair WP531,0.026563932201626964,7.303201506591337,26.497482392822498,"['POLE4', 'POLD4', 'POLE3']",0.45538169488503366,0,0,3
15,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.04029377973024186,14.586466165413533,46.84528460054168,"['ELOB', 'ELOC']",0.6447004756838698,0,0,2
16,Ciliary landscape WP4352,0.06142524409522222,2.0928843020097774,5.839009881579702,"['PSMD7', 'NDUFA5', 'SSNA1', 'COPS7A', 'MYL6B', 'COX6C', 'DCAF11', 'LSM4']",0.7811495983250876,0,0,8
17,Eukaryotic Transcription Initiation WP405,0.06184100986740276,4.379661016949153,12.189422371208211,"['POLR2I', 'POLR2J', 'POLR2K']",0.7811495983250876,0,0,3
18,Nanomaterial induced apoptosis WP2507,0.06184100986740276,4.379661016949153,12.189422371208211,"['ENDOG', 'BAX', 'CYCS']",0.7811495983250876,0,0,3
19,Nucleotide Excision Repair WP4753,0.06184100986740276,4.379661016949153,12.189422371208211,"['POLE4', 'POLD4', 'POLE3']",0.7811495983250876,0,0,3
20,Dual hijack model of Vif in HIV infection WP3300,0.0741806514762461,7.291353383458647,18.966647021578314,"['ELOB', 'ELOC']",0.8901678177149532,0,0,2
21,Ferroptosis WP4313,0.09773036285441201,2.6552315608919383,6.174855148073024,"['MAP1LC3A', 'GPX4', 'FTH1', 'FTL']",0.9999790388111127,0,0,4
22,Selenium Micronutrient Network WP15,0.1081701585552455,1.8959870686625906,4.216769565198002,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'TXN', 'F2', 'SELENOH']",0.9999790388111127,0,0,7
23,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.11391382276216513,4.859649122807017,10.556679242581144,"['MAP1LC3A', 'FTL']",0.9999790388111127,0,0,2
24,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.12095104502290648,inf,inf,['MAP1LC3A'],0.9999790388111127,0,0,1
25,Mitochondrial CII Assembly WP4920,0.12095104502290648,inf,inf,['SDHAF1'],0.9999790388111127,0,0,1
26,Non-homologous end joining WP438,0.12095104502290648,inf,inf,['DCLRE1C'],0.9999790388111127,0,0,1
27,Copper homeostasis WP3286,0.13886221665991175,2.735169491525424,5.399971508698922,"['SCO2', 'COX17', 'ATOX1']",0.9999790388111127,0,0,3
28,Serotonin and anxiety WP3947,0.15758879307191634,3.643796992481203,6.732884973514796,"['POMC', 'CRH']",0.9999790388111127,0,0,2
29,Androgen receptor signaling pathway WP138,0.16479442076894713,2.084636118598383,3.7587167384561013,"['SUMO1', 'BAG1', 'STUB1', 'PARK7']",0.9999790388111127,0,0,4
30,p38 MAPK Signaling Pathway WP400,0.20367486154411785,2.914285714285714,4.637299942929836,"['DDIT3', 'HRAS']",0.9999790388111127,0,0,2
31,Nanoparticle triggered autophagic cell death WP2509,0.22729710727721153,7.279549718574109,10.784633068802888,['MAP1LC3A'],0.9999790388111127,0,0,1
32,Nanoparticle triggered regulated necrosis WP2513,0.22729710727721153,7.279549718574109,10.784633068802888,['FTL'],0.9999790388111127,0,0,1
33,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.22729710727721153,7.279549718574109,10.784633068802888,['BAX'],0.9999790388111127,0,0,1
34,VEGFA-VEGFR2 Signaling Pathway WP3888,0.23274337081778598,1.2561592716331595,1.8312526587802047,"['SET', 'SDF2L1', 'SSR4', 'SARS', 'RPL13A', 'TXN', 'RPL10A', 'RPL7', 'RPL18A', 'TMSB4X', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'ELOC', 'TMSB10', 'HRAS']",0.9999790388111127,0,0,17
35,IL-18 signaling pathway WP4754,0.24186799608850584,1.3086292674558244,1.8574201884958037,"['NRN1', 'IMP3', 'NACA', 'TMSB4X', 'COX17', 'CYCS', 'BAX', 'NDUFC1', 'BPGM', 'RND2', 'NOX1', 'ITM2C']",0.9999790388111127,0,0,12
36,MET in type 1 papillary renal cell carcinoma WP4205,0.2509528172070967,2.4279448621553885,3.356610310152971,"['RPL11', 'HRAS']",0.9999790388111127,0,0,2
37,Parkinson's disease pathway WP2371,0.2509528172070967,2.4279448621553885,3.356610310152971,"['CYCS', 'PARK7']",0.9999790388111127,0,0,2
38,CAMKK2  Pathway WP4874,0.29846219299726606,2.0805585392051555,2.5156283189185538,"['FIS1', 'MAP1LC3A']",0.9999790388111127,0,0,2
39,TP53 network WP1742,0.29846219299726606,2.0805585392051555,2.5156283189185538,"['SUMO1', 'BAX']",0.9999790388111127,0,0,2
40,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.29846219299726606,2.0805585392051555,2.5156283189185538,"['MAP1LC3A', 'DDIT3']",0.9999790388111127,0,0,2
41,Serotonin and anxiety-related events WP3944,0.32079876314281075,3.6388367729831144,4.1371436602864184,['CRH'],0.9999790388111127,0,0,1
42,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.32079876314281075,3.6388367729831144,4.1371436602864184,['COX8A'],0.9999790388111127,0,0,1
43,"COVID-19, thrombosis and anticoagulation WP4927",0.32079876314281075,3.6388367729831144,4.1371436602864184,['F2'],0.9999790388111127,0,0,1
44,Homologous recombination WP186,0.32079876314281075,3.6388367729831144,4.1371436602864184,['POLD4'],0.9999790388111127,0,0,1
45,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.32079876314281075,3.6388367729831144,4.1371436602864184,['HRAS'],0.9999790388111127,0,0,1
46,MTHFR deficiency WP4288,0.32079876314281075,3.6388367729831144,4.1371436602864184,['CYCS'],0.9999790388111127,0,0,1
47,Nanoparticle-mediated activation of receptor signaling WP2643,0.32079876314281075,3.6388367729831144,4.1371436602864184,['HRAS'],0.9999790388111127,0,0,1
48,Peroxiredoxin 2 induced ovarian failure WP4873,0.32079876314281075,3.6388367729831144,4.1371436602864184,['BAX'],0.9999790388111127,0,0,1
49,Purine metabolism and related disorders WP4224,0.32079876314281075,3.6388367729831144,4.1371436602864184,['APRT'],0.9999790388111127,0,0,1
50,Purine metabolism WP4792,0.32079876314281075,3.6388367729831144,4.1371436602864184,['APRT'],0.9999790388111127,0,0,1
51,RalA downstream regulated genes WP2290,0.32079876314281075,3.6388367729831144,4.1371436602864184,['HRAS'],0.9999790388111127,0,0,1
52,Non-small cell lung cancer WP4255,0.33913408041649196,1.5605326876513317,1.6874972094347636,"['CYCS', 'BAX', 'HRAS']",0.9999790388111127,0,0,3
53,Type 2 papillary renal cell carcinoma WP4241,0.34545668791656786,1.8200187969924813,1.9344761467809775,"['ELOB', 'ELOC']",0.9999790388111127,0,0,2
54,DNA IR-double strand breaks and cellular response via ATM WP3959,0.34545668791656786,1.8200187969924813,1.9344761467809775,"['DCLRE1C', 'BAX']",0.9999790388111127,0,0,2
55,7q11.23 copy number variation syndrome WP4932,0.3580757523443912,1.3872416891284816,1.424712080746972,"['ATP5MC2', 'ATP5PO', 'ATP5F1E', 'ATP5MC1']",0.9999790388111127,0,0,4
56,TNF-alpha signaling pathway WP231,0.3580757523443912,1.3872416891284816,1.424712080746972,"['BAX', 'TXN', 'HRAS', 'NOX1']",0.9999790388111127,0,0,4
57,Modulators of TCR signaling and T cell activation WP5072,0.37400200409729023,1.456120527306968,1.4320859810342,"['NDUFB10', 'ELOB', 'RNF7']",0.9999790388111127,0,0,3
58,Translation Factors WP107,0.39136655811577564,1.617376775271512,1.5172784092860319,"['EEF1B2', 'EIF1']",0.9999790388111127,0,0,2
59,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.40300477574948235,2.4252657911194495,2.2040982043253323,['HRAS'],0.9999790388111127,0,0,1
60,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.40300477574948235,2.4252657911194495,2.2040982043253323,['DLL3'],0.9999790388111127,0,0,1
61,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.40300477574948235,2.4252657911194495,2.2040982043253323,['IDH3B'],0.9999790388111127,0,0,1
62,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.40300477574948235,2.4252657911194495,2.2040982043253323,['SST'],0.9999790388111127,0,0,1
63,Type II diabetes mellitus WP1584,0.40300477574948235,2.4252657911194495,2.2040982043253323,['SURF1'],0.9999790388111127,0,0,1
64,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.40300477574948235,2.4252657911194495,2.2040982043253323,['VIP'],0.9999790388111127,0,0,1
65,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.40300477574948235,2.4252657911194495,2.2040982043253323,['MAP1LC3A'],0.9999790388111127,0,0,1
66,Fatty acid transporters WP5061,0.40300477574948235,2.4252657911194495,2.2040982043253323,['FABP6'],0.9999790388111127,0,0,1
67,Gastric acid production WP2596,0.40300477574948235,2.4252657911194495,2.2040982043253323,['VIP'],0.9999790388111127,0,0,1
68,Genes targeted by miRNAs in adipocytes WP1992,0.40300477574948235,2.4252657911194495,2.2040982043253323,['TMSB4X'],0.9999790388111127,0,0,1
69,Glycosylation and related congenital defects WP4521,0.40300477574948235,2.4252657911194495,2.2040982043253323,['DPM3'],0.9999790388111127,0,0,1
70,Iron metabolism in placenta WP2007,0.40300477574948235,2.4252657911194495,2.2040982043253323,['FTH1'],0.9999790388111127,0,0,1
71,Methionine De Novo and Salvage Pathway WP3580,0.40300477574948235,2.4252657911194495,2.2040982043253323,['TXN'],0.9999790388111127,0,0,1
72,Nanomaterial-induced inflammasome activation WP3890,0.40300477574948235,2.4252657911194495,2.2040982043253323,['NOX1'],0.9999790388111127,0,0,1
73,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.40300477574948235,2.4252657911194495,2.2040982043253323,['EIF1'],0.9999790388111127,0,0,1
74,Overview of nanoparticle effects WP3287,0.40300477574948235,2.4252657911194495,2.2040982043253323,['BAX'],0.9999790388111127,0,0,1
75,Pyrimidine metabolism and related diseases WP4225,0.40300477574948235,2.4252657911194495,2.2040982043253323,['NT5C'],0.9999790388111127,0,0,1
76,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.40300477574948235,2.4252657911194495,2.2040982043253323,['ANAPC11'],0.9999790388111127,0,0,1
77,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.40849127357458714,1.3647598870056497,1.2218486828976634,"['PSMC5', 'PSMD7', 'STUB1']",0.9999790388111127,0,0,3
78,Alzheimer's disease WP2059,0.44238196938447055,1.2841475573280159,1.0473271014235332,"['PSENEN', 'ATP5MD', 'CYCS']",0.9999790388111127,0,0,3
79,Senescence and Autophagy in Cancer WP615,0.47229926074162326,1.1640754716981132,0.8732224464767876,"['GABARAPL2', 'MAP1LC3A', 'HRAS', 'GABARAP']",0.9999790388111127,0,0,4
80,Apoptosis Modulation by HSP70 WP384,0.4752774806841921,1.8184803001876173,1.3526883471307527,['CYCS'],0.9999790388111127,0,0,1
81,Biomarkers for pyrimidine metabolism disorders WP4584,0.4752774806841921,1.8184803001876173,1.3526883471307527,['NT5C'],0.9999790388111127,0,0,1
82,Glutathione metabolism WP100,0.4752774806841921,1.8184803001876173,1.3526883471307527,['GPX4'],0.9999790388111127,0,0,1
83,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.4752774806841921,1.8184803001876173,1.3526883471307527,['BAX'],0.9999790388111127,0,0,1
84,MAPK Cascade WP422,0.4752774806841921,1.8184803001876173,1.3526883471307527,['HRAS'],0.9999790388111127,0,0,1
85,miRNA regulation of p53 pathway in prostate cancer WP3982,0.4752774806841921,1.8184803001876173,1.3526883471307527,['BAX'],0.9999790388111127,0,0,1
86,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.4752774806841921,1.8184803001876173,1.3526883471307527,['SCO2'],0.9999790388111127,0,0,1
87,Nucleotide metabolism WP404,0.4752774806841921,1.8184803001876173,1.3526883471307527,['NME2'],0.9999790388111127,0,0,1
88,Acute viral myocarditis WP4298,0.4754886931807981,1.2124921531701194,0.9013814300669053,"['ENDOG', 'CYCS', 'BAX']",0.9999790388111127,0,0,3
89,Notch Signaling Pathway Netpath WP61,0.478351277617114,1.3226247436773753,0.9753166143318638,"['PSENEN', 'DLL3']",0.9999790388111127,0,0,2
90,Sleep regulation WP3591,0.5189089318578051,1.212092731829574,0.7951654127627981,"['CRH', 'HCRTR1']",0.9999790388111127,0,0,2
91,Synaptic Vesicle Pathway WP2267,0.5189089318578051,1.212092731829574,0.7951654127627981,"['SLC32A1', 'PARK7']",0.9999790388111127,0,0,2
92,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5189089318578051,1.212092731829574,0.7951654127627981,"['APEX1', 'HRAS']",0.9999790388111127,0,0,2
93,BDNF-TrkB Signaling WP3676,0.5388151802107881,1.4544090056285177,0.8993813106934605,['HRAS'],0.9999790388111127,0,0,1
94,Energy Metabolism WP1541,0.5388151802107881,1.4544090056285177,0.8993813106934605,['UCP3'],0.9999790388111127,0,0,1
95,ERK Pathway in Huntington's Disease WP3853,0.5388151802107881,1.4544090056285177,0.8993813106934605,['HRAS'],0.9999790388111127,0,0,1
96,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.5388151802107881,1.4544090056285177,0.8993813106934605,['H2AFZ'],0.9999790388111127,0,0,1
97,Galanin receptor pathway WP4970,0.5388151802107881,1.4544090056285177,0.8993813106934605,['POMC'],0.9999790388111127,0,0,1
98,Gastric Cancer Network 2 WP2363,0.5388151802107881,1.4544090056285177,0.8993813106934605,['S100A6'],0.9999790388111127,0,0,1
99,Histone Modifications WP2369,0.5388151802107881,1.4544090056285177,0.8993813106934605,['SET'],0.9999790388111127,0,0,1
100,Interleukin-11 Signaling Pathway WP2332,0.5388151802107881,1.4544090056285177,0.8993813106934605,['HRAS'],0.9999790388111127,0,0,1
101,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5388151802107881,1.4544090056285177,0.8993813106934605,['BAX'],0.9999790388111127,0,0,1
102,NOTCH1 regulation of endothelial cell calcification WP3413,0.5388151802107881,1.4544090056285177,0.8993813106934605,['DLL3'],0.9999790388111127,0,0,1
103,PDGFR-beta pathway WP3972,0.5388151802107881,1.4544090056285177,0.8993813106934605,['HRAS'],0.9999790388111127,0,0,1
104,Photodynamic therapy-induced unfolded protein response WP3613,0.5388151802107881,1.4544090056285177,0.8993813106934605,['DDIT3'],0.9999790388111127,0,0,1
105,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.5388151802107881,1.4544090056285177,0.8993813106934605,['HRAS'],0.9999790388111127,0,0,1
106,Cytosolic DNA-sensing pathway WP4655,0.5573065995867497,1.1185656448814343,0.6539579304862512,"['POLR2K', 'POLR2L']",0.9999790388111127,0,0,2
107,Genotoxicity pathway WP4286,0.5573065995867497,1.1185656448814343,0.6539579304862512,"['RPS27', 'TRIAP1']",0.9999790388111127,0,0,2
108,Leptin signaling pathway WP2034,0.5573065995867497,1.1185656448814343,0.6539579304862512,"['BAX', 'HRAS']",0.9999790388111127,0,0,2
109,Regulation of Actin Cytoskeleton WP51,0.578109570258393,1.0024723487312948,0.5493466873350993,"['FGF17', 'TMSB4X', 'BRK1', 'F2']",0.9999790388111127,0,0,4
110,G Protein Signaling Pathways WP35,0.5934727117939332,1.0383995703544575,0.5417995595653216,"['GNG10', 'HRAS']",0.9999790388111127,0,0,2
111,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.5934727117939332,1.0383995703544575,0.5417995595653216,"['IFI27L2', 'HRAS']",0.9999790388111127,0,0,2
112,Signaling of Hepatocyte Growth Factor Receptor WP313,0.5946718590779271,1.2116948092557849,0.6297729522501931,['HRAS'],0.9999790388111127,0,0,1
113,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.5946718590779271,1.2116948092557849,0.6297729522501931,['HRAS'],0.9999790388111127,0,0,1
114,ATM Signaling Network in Development and Disease  WP3878,0.5946718590779271,1.2116948092557849,0.6297729522501931,['DCLRE1C'],0.9999790388111127,0,0,1
115,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.5946718590779271,1.2116948092557849,0.6297729522501931,['HRAS'],0.9999790388111127,0,0,1
116,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.5946718590779271,1.2116948092557849,0.6297729522501931,['HRAS'],0.9999790388111127,0,0,1
117,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.5946718590779271,1.2116948092557849,0.6297729522501931,['SUPT4H1'],0.9999790388111127,0,0,1
118,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5946718590779271,1.2116948092557849,0.6297729522501931,['HRAS'],0.9999790388111127,0,0,1
119,Exercise-induced Circadian Regulation WP410,0.6273845022427225,0.9689223057644111,0.45170739813318495,"['SUMO1', 'UCP3']",0.9999790388111127,0,0,2
120,Melanoma WP4685,0.6273845022427225,0.9689223057644111,0.45170739813318495,"['BAX', 'HRAS']",0.9999790388111127,0,0,2
121,Transcriptional cascade regulating adipogenesis WP4211,0.6437745366269558,1.038327526132404,0.45728641236725415,['DDIT3'],0.9999790388111127,0,0,1
122,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6437745366269558,1.038327526132404,0.45728641236725415,['HRAS'],0.9999790388111127,0,0,1
123,One-carbon metabolism and related pathways WP3940,0.6437745366269558,1.038327526132404,0.45728641236725415,['GPX4'],0.9999790388111127,0,0,1
124,Oxidative Stress WP408,0.6437745366269558,1.038327526132404,0.45728641236725415,['NOX1'],0.9999790388111127,0,0,1
125,PDGF Pathway WP2526,0.6437745366269558,1.038327526132404,0.45728641236725415,['HRAS'],0.9999790388111127,0,0,1
126,Regulation of Microtubule Cytoskeleton WP2038,0.6437745366269558,1.038327526132404,0.45728641236725415,['PARD6A'],0.9999790388111127,0,0,1
127,SARS-CoV-2 mitochondrial interactions WP5038,0.6437745366269558,1.038327526132404,0.45728641236725415,['NOX1'],0.9999790388111127,0,0,1
128,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.659057286120619,0.9081296992481203,0.378639973440128,"['CYCS', 'BAX']",0.9999790388111127,0,0,2
129,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.659057286120619,0.9081296992481203,0.378639973440128,"['BAX', 'HRAS']",0.9999790388111127,0,0,2
130,EGF/EGFR signaling pathway WP437,0.6758361165796272,0.871412429378531,0.3414234535975113,"['NDUFA13', 'NEDD8', 'HRAS']",0.9999790388111127,0,0,3
131,Alpha 6 Beta 4 signaling pathway WP244,0.6869385355293113,0.9083020637898687,0.3410769246085538,['HRAS'],0.9999790388111127,0,0,1
132,Amyotrophic lateral sclerosis (ALS) WP2447,0.6869385355293113,0.9083020637898687,0.3410769246085538,['BAX'],0.9999790388111127,0,0,1
133,Striated Muscle Contraction Pathway WP383,0.6869385355293113,0.9083020637898687,0.3410769246085538,['TPM2'],0.9999790388111127,0,0,1
134,Canonical and non-canonical Notch signaling WP3845,0.6869385355293113,0.9083020637898687,0.3410769246085538,['DLL3'],0.9999790388111127,0,0,1
135,Unfolded protein response WP4925,0.6869385355293113,0.9083020637898687,0.3410769246085538,['DDIT3'],0.9999790388111127,0,0,1
136,GABA receptor Signaling WP4159,0.6869385355293113,0.9083020637898687,0.3410769246085538,['SLC32A1'],0.9999790388111127,0,0,1
137,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6869385355293113,0.9083020637898687,0.3410769246085538,['DDIT3'],0.9999790388111127,0,0,1
138,IL1 and megakaryocytes in obesity WP2865,0.6869385355293113,0.9083020637898687,0.3410769246085538,['F2'],0.9999790388111127,0,0,1
139,DNA damage response WP707,0.6885356111437769,0.8544891640866873,0.3188853066950159,"['CYCS', 'BAX']",0.9999790388111127,0,0,2
140,Endometrial cancer WP4155,0.6885356111437769,0.8544891640866873,0.3188853066950159,"['BAX', 'HRAS']",0.9999790388111127,0,0,2
141,Folate Metabolism WP176,0.6885356111437769,0.8544891640866873,0.3188853066950159,"['GPX4', 'F2']",0.9999790388111127,0,0,2
142,miRNA regulation of DNA damage response WP1530,0.6885356111437769,0.8544891640866873,0.3188853066950159,"['CYCS', 'BAX']",0.9999790388111127,0,0,2
143,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7158859854388929,0.8068086883876358,0.2696631879575916,"['POMC', 'HRAS']",0.9999790388111127,0,0,2
144,Vitamin D-sensitive calcium signaling in depression WP4698,0.7248809180861877,0.8071711486345633,0.2597056127585117,['GPX4'],0.9999790388111127,0,0,1
145,IL-2 signaling pathway WP49,0.7248809180861877,0.8071711486345633,0.2597056127585117,['HRAS'],0.9999790388111127,0,0,1
146,IL-6 signaling pathway WP364,0.7248809180861877,0.8071711486345633,0.2597056127585117,['VIP'],0.9999790388111127,0,0,1
147,Notch Signaling WP268,0.7248809180861877,0.8071711486345633,0.2597056127585117,['DLL3'],0.9999790388111127,0,0,1
148,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7248809180861877,0.8071711486345633,0.2597056127585117,['BAX'],0.9999790388111127,0,0,1
149,Blood Clotting Cascade WP272,0.7582323083740407,0.726266416510319,0.20100546238223974,['F2'],0.9999790388111127,0,0,1
150,DNA Replication WP466,0.7582323083740407,0.726266416510319,0.20100546238223974,['POLD4'],0.9999790388111127,0,0,1
151,Endothelin Pathways WP2197,0.7582323083740407,0.726266416510319,0.20100546238223974,['RIIAD1'],0.9999790388111127,0,0,1
152,Integrated Cancer Pathway WP1971,0.7582323083740407,0.726266416510319,0.20100546238223974,['BAX'],0.9999790388111127,0,0,1
153,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7582323083740407,0.726266416510319,0.20100546238223974,['CYCS'],0.9999790388111127,0,0,1
154,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7645441580907554,0.7257518796992481,0.19484659481162353,"['BAX', 'HRAS']",0.9999790388111127,0,0,2
155,Apoptosis WP254,0.7860466493576336,0.6910132474042249,0.16635393351721625,"['CYCS', 'BAX']",0.9999790388111127,0,0,2
156,Corticotropin-releasing hormone signaling pathway WP2355,0.7860466493576336,0.6910132474042249,0.16635393351721625,"['POMC', 'CRH']",0.9999790388111127,0,0,2
157,Cardiac Progenitor Differentiation WP2406,0.7875472949731329,0.6600716356813918,0.15764613184732276,['MESP1'],0.9999790388111127,0,0,1
158,Kit receptor signaling pathway WP304,0.7875472949731329,0.6600716356813918,0.15764613184732276,['HRAS'],0.9999790388111127,0,0,1
159,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7875472949731329,0.6600716356813918,0.15764613184732276,['BAX'],0.9999790388111127,0,0,1
160,Pregnane X receptor pathway WP2876,0.7875472949731329,0.6600716356813918,0.15764613184732276,['PSMC5'],0.9999790388111127,0,0,1
161,Breast cancer pathway WP4262,0.7968254067627586,0.7247169811320755,0.16459749407966606,"['FGF17', 'BAX', 'HRAS', 'DLL3']",0.9999790388111127,0,0,4
162,ESC Pluripotency Pathways WP3931,0.8058035501474827,0.6594326725905674,0.1423816036565537,"['FGF17', 'HRAS']",0.9999790388111127,0,0,2
163,16p11.2 proximal deletion syndrome WP4949,0.8133135831584996,0.6049093183239524,0.12499757393062935,['SEZ6L2'],0.9999790388111127,0,0,1
164,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8133135831584996,0.6049093183239524,0.12499757393062935,['HRAS'],0.9999790388111127,0,0,1
165,Bladder cancer WP2828,0.8133135831584996,0.6049093183239524,0.12499757393062935,['HRAS'],0.9999790388111127,0,0,1
166,Fas ligand pathway and stress induction of heat shock proteins WP314,0.8133135831584996,0.6049093183239524,0.12499757393062935,['CYCS'],0.9999790388111127,0,0,1
167,Pathways affected in adenoid cystic carcinoma WP3651,0.8133135831584996,0.6049093183239524,0.12499757393062935,['HRAS'],0.9999790388111127,0,0,1
168,PPAR signaling pathway WP3942,0.8133135831584996,0.6049093183239524,0.12499757393062935,['FABP6'],0.9999790388111127,0,0,1
169,Hepatitis B infection WP4666,0.8136351976684619,0.6795550847457628,0.14015359727715704,"['CYCS', 'BAX', 'HRAS']",0.9999790388111127,0,0,3
170,TGF-beta Signaling Pathway WP366,0.8239216843116229,0.6305982347172279,0.12213413802597534,"['PARD6A', 'SUMO1']",0.9999790388111127,0,0,2
171,DNA damage response (only ATM dependent) WP710,0.8239216843116229,0.6305982347172279,0.12213413802597534,"['BAX', 'HRAS']",0.9999790388111127,0,0,2
172,Aryl Hydrocarbon Receptor Pathway WP2873,0.8359600480548185,0.5582335113291962,0.10002118596318663,['BAX'],0.9999790388111127,0,0,1
173,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.8359600480548185,0.5582335113291962,0.10002118596318663,['NDUFA13'],0.9999790388111127,0,0,1
174,Oxidative Damage WP3941,0.8359600480548185,0.5582335113291962,0.10002118596318663,['CYCS'],0.9999790388111127,0,0,1
175,p53 transcriptional gene network WP4963,0.8359600480548185,0.5582335113291962,0.10002118596318663,['BAX'],0.9999790388111127,0,0,1
176,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8359600480548185,0.5582335113291962,0.10002118596318663,['BAX'],0.9999790388111127,0,0,1
177,Apoptosis Modulation and Signaling WP1772,0.8554719863950955,0.6208232445520581,0.09691170758654649,"['ENDOG', 'CYCS', 'BAX']",0.9999790388111127,0,0,3
178,Small cell lung cancer WP4658,0.855666145540832,0.5798496240601504,0.0903840577198293,"['CYCS', 'BAX']",0.9999790388111127,0,0,2
179,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.8558638190640947,0.5182256767622622,0.08065872001941021,['RNF7'],0.9999790388111127,0,0,1
180,Aryl Hydrocarbon Receptor Netpath WP2586,0.8558638190640947,0.5182256767622622,0.08065872001941021,['HRAS'],0.9999790388111127,0,0,1
181,IL-3 signaling pathway WP286,0.8558638190640947,0.5182256767622622,0.08065872001941021,['HRAS'],0.9999790388111127,0,0,1
182,MECP2 and Associated Rett Syndrome WP3584,0.8558638190640947,0.5182256767622622,0.08065872001941021,['SST'],0.9999790388111127,0,0,1
183,Oncostatin M Signaling Pathway WP2374,0.8558638190640947,0.5182256767622622,0.08065872001941021,['HRAS'],0.9999790388111127,0,0,1
184,Prolactin Signaling Pathway WP2037,0.8558638190640947,0.5182256767622622,0.08065872001941021,['HRAS'],0.9999790388111127,0,0,1
185,Prostaglandin Synthesis and Regulation WP98,0.8558638190640947,0.5182256767622622,0.08065872001941021,['S100A6'],0.9999790388111127,0,0,1
186,Circadian rhythm related genes WP3594,0.8606049881199137,0.6433542976939204,0.09658013003695626,"['CRH', 'AVP', 'RPS27A', 'HCRTR1']",0.9999790388111127,0,0,4
187,Glioblastoma signaling pathways WP2261,0.8733565128372499,0.483552220137586,0.0654784975266027,['HRAS'],0.9999790388111127,0,0,1
188,Head and Neck Squamous Cell Carcinoma WP4674,0.8733565128372499,0.483552220137586,0.0654784975266027,['HRAS'],0.9999790388111127,0,0,1
189,Pancreatic adenocarcinoma pathway WP4263,0.8733565128372499,0.483552220137586,0.0654784975266027,['BAX'],0.9999790388111127,0,0,1
190,22q11.2 copy number variation syndrome WP4657,0.8821049413052908,0.5366193260930103,0.06731580835057492,"['RANBP1', 'MRPL40']",0.9999790388111127,0,0,2
191,AGE/RAGE pathway WP2324,0.8887297170768049,0.4532129455909944,0.05346195986412102,['CYCS'],0.9999790388111127,0,0,1
192,T-cell receptor (TCR) signaling pathway WP69,0.8887297170768049,0.4532129455909944,0.05346195986412102,['HRAS'],0.9999790388111127,0,0,1
193,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8887297170768049,0.4532129455909944,0.05346195986412102,['HRAS'],0.9999790388111127,0,0,1
194,TGF-beta Receptor Signaling WP560,0.8887297170768049,0.4532129455909944,0.05346195986412102,['HRAS'],0.9999790388111127,0,0,1
195,Thermogenesis WP4321,0.8887297170768049,0.4532129455909944,0.05346195986412102,['HRAS'],0.9999790388111127,0,0,1
196,White fat cell differentiation WP4149,0.8887297170768049,0.4532129455909944,0.05346195986412102,['DDIT3'],0.9999790388111127,0,0,1
197,ErbB signaling pathway WP673,0.8887297170768049,0.4532129455909944,0.05346195986412102,['HRAS'],0.9999790388111127,0,0,1
198,NRF2 pathway WP2884,0.8888657957627979,0.571364852809991,0.0673119309498113,"['FTH1', 'TXN', 'FTL']",0.9999790388111127,0,0,3
199,Vitamin B12 metabolism WP1533,0.9022398139544997,0.4264429974616488,0.04387029143492425,['F2'],0.9999790388111127,0,0,1
200,Prader-Willi and Angelman Syndrome WP3998,0.9022398139544997,0.4264429974616488,0.04387029143492425,['POMC'],0.9999790388111127,0,0,1
201,Pre-implantation embryo WP3527,0.9022398139544997,0.4264429974616488,0.04387029143492425,['DDIT3'],0.9999790388111127,0,0,1
202,Chemokine signaling pathway WP3929,0.9040053441104619,0.49935182784547577,0.05039458995204917,"['GNG10', 'HRAS']",0.9999790388111127,0,0,2
203,Integrated breast cancer pathway WP1984,0.9040053441104619,0.49935182784547577,0.05039458995204917,"['BAX', 'FAU']",0.9999790388111127,0,0,2
204,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9141122240637453,0.40264748801334166,0.03615852218783814,['TMSB4X'],0.9999790388111127,0,0,1
205,Male infertility WP4673,0.9141122240637453,0.40264748801334166,0.03615852218783814,['PEX10'],0.9999790388111127,0,0,1
206,Integrin-mediated Cell Adhesion WP185,0.9245451389145621,0.38135676903327737,0.029918736718032763,['HRAS'],0.9999790388111127,0,0,1
207,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9337128047543587,0.3621951219512195,0.024841651396946288,['CTSV'],0.9999790388111127,0,0,1
208,Endochondral Ossification WP474,0.9337128047543587,0.3621951219512195,0.024841651396946288,['CTSV'],0.9999790388111127,0,0,1
209,Retinoblastoma gene in cancer WP2446,0.9337128047543587,0.3621951219512195,0.024841651396946288,['H2AFZ'],0.9999790388111127,0,0,1
210,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.936883707322723,0.4383686488949647,0.028579933354939954,"['HRAS', 'DLL3']",0.9999790388111127,0,0,2
211,Peptide GPCRs WP24,0.9417684108343846,0.34485839363888143,0.02069008383721618,['HCRTR1'],0.9999790388111127,0,0,1
212,MAPK Signaling Pathway WP382,0.946743564687284,0.47101449275362317,0.02577721461510396,"['FGF17', 'DDIT3', 'HRAS']",0.9999790388111127,0,0,3
213,Insulin Signaling WP481,0.9488466297051843,0.3290977315367559,0.017280298561022856,['HRAS'],0.9999790388111127,0,0,1
214,Proximal tubule transport WP4917,0.9550658517486277,0.31470756179133696,0.014468675800343337,['SLC7A9'],0.9999790388111127,0,0,1
215,Ras signaling WP4223,0.9588930162767505,0.3905710221499695,0.016394518576541436,"['GNG10', 'HRAS']",0.9999790388111127,0,0,2
216,B Cell Receptor Signaling Pathway WP23,0.9695488513986718,0.2781786693606581,0.008602513263302568,['HRAS'],0.9999790388111127,0,0,1
217,Cell cycle WP179,0.9695488513986718,0.2781786693606581,0.008602513263302568,['ANAPC11'],0.9999790388111127,0,0,1
218,Ciliopathies WP4803,0.9695488513986718,0.2781786693606581,0.008602513263302568,['CCDC28B'],0.9999790388111127,0,0,1
219,Complement and Coagulation Cascades WP558,0.9695488513986718,0.2781786693606581,0.008602513263302568,['F2'],0.9999790388111127,0,0,1
220,Gastrin signaling pathway WP4659,0.9695488513986718,0.2781786693606581,0.008602513263302568,['HRAS'],0.9999790388111127,0,0,1
221,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9732543555779429,0.2678062678062678,0.007260178967808283,['HRAS'],0.9999790388111127,0,0,1
222,Complement system WP2806,0.9762143814466896,0.3436269244539921,0.008272152795937465,"['RPS19', 'TXN']",0.9999790388111127,0,0,2
223,Ectoderm Differentiation WP2858,0.9765096539276776,0.2581747520771911,0.006136979723725344,['LY6E'],0.9999790388111127,0,0,1
224,Endoderm differentiation WP2853,0.9818814518127021,0.24083802376485303,0.004403650792377622,['NME1'],0.9999790388111127,0,0,1
225,Neural Crest Differentiation WP2064,0.9818814518127021,0.24083802376485303,0.004403650792377622,['DLL3'],0.9999790388111127,0,0,1
226,Osteoblast differentiation WP4787,0.9818814518127021,0.24083802376485303,0.004403650792377622,['DLL3'],0.9999790388111127,0,0,1
227,Myometrial relaxation and contraction pathways WP289,0.9847604005202525,0.3134194181104936,0.004813155552101279,"['CRH', 'IGFBP6']",0.9999790388111127,0,0,2
228,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9891277244656125,0.29400030688967316,0.0032139556820330773,"['SST', 'AVP']",0.9999790388111127,0,0,2
229,Mesodermal commitment pathway WP2857,0.9892244300167348,0.21228341242688445,0.002299888445962324,['RPL38'],0.9999790388111127,0,0,1
230,Hippo-Merlin Signaling Dysregulation WP4541,0.990537867321093,0.2061645671401769,0.001960044280978355,['HRAS'],0.9999790388111127,0,0,1
231,Adipogenesis WP236,0.9916914331875152,0.20038565770273087,0.0016718727163017564,['DDIT3'],0.9999790388111127,0,0,1
232,Vitamin D Receptor Pathway WP2877,0.9931001526393463,0.27152787629450986,0.0018799942215699504,"['S100A6', 'NOX1']",0.9999790388111127,0,0,2
233,Regulation of toll-like receptor signaling pathway WP1449,0.9935943023196397,0.18974029821269872,0.0012193284957872207,['CUEDC2'],0.9999790388111127,0,0,1
234,Nuclear Receptors Meta-Pathway WP2882,0.9939994721873754,0.3892701569820005,0.0023428626608705556,"['PSMC5', 'FTH1', 'BAX', 'TXN', 'FTL']",0.9999790388111127,0,0,5
235,Metapathway biotransformation Phase I and II WP702,0.9966581263777662,0.16745931323356167,0.0005605650530531699,['GPX4'],0.9999790388111127,0,0,1
236,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9977606750243938,0.2791107197886859,0.0006257204632829162,"['FGF17', 'GNG10', 'HRAS']",0.9999790388111127,0,0,3
237,Spinal Cord Injury WP2431,0.9988209116229797,0.140896884081963,0.0001662278963392221,['APEX1'],0.9999790388111127,0,0,1
238,Focal Adhesion WP306,0.9990912503107866,0.13550922156536516,0.00012319995042373548,['HRAS'],0.9999790388111127,0,0,1
239,PI3K-Akt signaling pathway WP4172,0.9993969891725535,0.2407160540849362,0.00014519816938864935,"['FGF17', 'GNG10', 'HRAS']",0.9999790388111127,0,0,3
240,"GPCRs, Class A Rhodopsin-like WP455",0.9999790388111127,0.08585185017744525,1.7995757085810172e-06,['HCRTR1'],0.9999790388111127,0,0,1
